Internal radiation therapy shows promise in pilot study for multiple cancers
NCT ID NCT00924027
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This pilot study tested high dose rate brachytherapy, a type of internal radiation, in 43 patients with cervical, endometrial, esophageal, prostate, or biliary cancer. The goal was to see if the radiation implants could deliver the planned dose accurately. Participants received brachytherapy as part of their treatment and were followed for up to a year. The study focused on implant quality and local tumor control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
High Dose Rate Brachytherapy (internal radiation)
What this could lead to
If successful, this could help refine brachytherapy techniques to better target tumors while sparing healthy tissue, potentially improving cancer control.
What could go wrong
This is a small, early-phase pilot study (43 participants) focused on procedure quality, not survival. Results may not apply to all patients or cancer types.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States